Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

F. Javier Ibarrondo; Jennifer A. Fulcher; David Goodman‐Meza; Julie Elliott; Christian Hofmann; Mary Ann Hausner; Kathie G. Ferbas; Nicole H. Tobin; Grace M. Aldrovandi; Otto O. Yang

doi:10.1056/nejmc2025179

Abstract

Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyVirology2019-20 coronavirus outbreakSpike ProteinBetacoronavirusMedicineImmunologyBiologyOutbreakInternal medicineInfectious disease (medical specialty)Disease

Affiliated Institutions

University of California, Los Angeles US

Related Publications

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg , Fatima Amanat , Adolfo Firpo +15 more

SARS-CoV-2 antibodies persist As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome ...

2020 Science 1241 citations

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Xiaolong Tian , Cheng Li , Ailing Huang +8 more

The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human...

2020 Emerging Microbes & Infections 1257 citations

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Xiaolong Tian , Cheng Li , Ailing Huang +8 more

ABSTRACT The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 800 laboratory-confirmed human infections, including 25 deaths, posing a serious threat to ...

2020 bioRxiv (Cold Spring Harbor Laboratory) 187 citations

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer , Tom G. Caniels , Karlijn van der Straten +30 more

Sites of vulnerability in SARS-CoV-2 Antibodies that neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be an important tool in treating coronavirus d...

2020 Science 1318 citations

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

Johanna K. Hansen , Alina Baum , Kristen E. Pascal +44 more

An antibody cocktail against SARS-CoV-2 There is an urgent focus on antibodies that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral spike and preve...

2020 Science 1398 citations

Publication Info

Year: 2020
Type: letter
Volume: 383
Issue: 11
Pages: 1085-1087
Citations: 1147
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1147

OpenAlex

Cite This

APA Style

                            
                                
                                    F. Javier Ibarrondo, 
                                
                                    Jennifer A. Fulcher, 
                                
                                    David Goodman‐Meza
                                
                                et al.
                            
                            (2020). 
                            Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19. 
                            New England Journal of Medicine
                            , 383
                            (11)
                            , 1085-1087.
                            https://doi.org/10.1056/nejmc2025179
                        

Identifiers

DOI: 10.1056/nejmc2025179